Print

Novel Translational Methodologies

  1. What's It All About?
  2. Who is Responsible?
  3. Tell Me More.
  4. Resources.
The overall goal of the NTM component is to speed the development and application of new technologies that will improve the health and well-being of our population. The expertise within the GHUCCTS provides the capacity to apply this knowledge to understanding the pathogenesis of disease states, development of new techniques to diagnose disease, and the discovery of novel methods for the prevention and treatment of disease (type 1 translation). In addition, our unique strength in population studies, health policy, and decision-making positions us to develop novel methodologies to assess the potential impact of resource allocation into specific areas on the downstream benefits to our community (type 2 translation). GHUCCTS will accomplish these goals by capitalizing upon a stong partnership that we have developed with the Oak Ridge National Laboratory (ORNL) in order to develop innovative and truly transformational translational methodologies.

The NTM component will ensure future progress in the development of new methodologies in clinical and translational science by establishing training and mentoring programs to promote the development of a cadre of investigators focusing on research in this area.